Laserfiche WebLink
Required DOT Drug Tests & Cutoffs <br />TYPE OF DRUG <br />INITIAL TEST <br />CONFIRMATORY TEST <br />CONFIRMATORY TEST <br />Initial Test Analyte <br />Cutoff Concentration9 <br />Analyte <br />Cutoff Concentration <br />Marijuana metabolites THCA 10 <br />50 n /mL" <br />THCA <br />15 ng/mL <br />Cocaine metabolite <br />150 ng/mL" <br />Benzoylecgonine <br />100 ng/mL <br />(Benzoylecgonine) <br />Opioids: <br />Codeine/Morphine <br />2000 ng/mL <br />Codeine <br />2000 ng/mL <br />Morphine <br />2000 ng/mL <br />Hydrocodone/Hydromorphone <br />300 ng/mL <br />Hydrocodone <br />100 ng/mL <br />Hydromorphone <br />100 ng/mL <br />Oxycodone/Oxymorphone <br />100 ng/mL <br />Oxycodone <br />100 ng/mL <br />Oxymorphone <br />100 ng/mL <br />6-Acet Imor hine <br />10 n /mL <br />6-Acet Imor hine <br />10 n /mL <br />Phencyclidine <br />25 n /mL <br />Phencyclidine <br />25 n /mL <br />Amphetamine/Methamphetamine <br />500 ng/mL <br />Amphetamine <br />250 ng/mL <br />Methamphetamine <br />250 ng/mL <br />MDMA'2/MDA" <br />500 ng/mL <br />MDMA <br />250 ng/mL <br />MDA <br />250 n /mL <br />Table 1 <br />9 For grouped analytes (i.e., two or more analytes that are in the same drug class and have the same initial test cutoff): <br />Inrnnrnoassay; The test must be calibrated with one analyte from the group identified as the target analyte, The cross -reactivity <br />of the immunoassay to the other analyte(s) within the group must be 80 percent or greater. If not, separate immunoassays must be <br />used for the analytes within the group. <br />Alternate techn0000: Either one analyte or all analytes from the group must be used for calibration, depending on the <br />technology. At least one analyte within the group must have a concentration equal to or greater than the initial test cutoff or, <br />alternatively, the sum of the analytes present (i.e,, equal to or greater than the laboratory's validated limit of quantification) must <br />be equal to or greater than the initial test cutoff. <br />10 An immunoassay must be calibrated with the target analyte Delta-9-tetrahydrocannabinol-9-carboxylic acid (THCA) <br />" Alternate technology (THCA and benzoylecgonine): When using alternate technology to test for THCA and Benzoylecgonine, <br />the screening and confirmatory test cutoff concentrations must be the same respectively (i.e., 15 ng/mL for THCA and 100 ng/mL <br />for Benzoyleegnine). <br />Methylenedioxymethamphetamine (MDMA) <br />Methylenedioxyamphetamine (MDA) <br />Premium Concrete Services, Inc.- PHMSADRUG/ALCOHOL PLAN 25 <br />(Fl NATIONAL GOMP�IANGE MANAGEMENT SERVICE, INC. (NCMS) 2°t 1 (update 2°21). The NCMS plan I<_ <br />the subject of a registered copyright and Is prolecletl by copyright Taws in ode U S. antl else,vhere. All rigFis <br />e.arved. <br />